The DARTBAC project will prepare the Netherlands for the time when antibiotics are much less effective in the prevention and eradication of infection due to AntiMicrobial Resistance (AMR)

An interdisciplinary consortium consisting of 9 Academic partners and the RIVM will work together with 10 (inter)national industry partners. In addition, cooperation partners AMR-Insights (online information platform), the ReumaNederland health fund, the Knowledge Institute of the Federation Medical Specialists, the Dutch Orthopedic Association and PR-agency The Nudge are available for communication and dissemination of project results.